Skip to main content
SpringerLink
Log in

Benign Hematologic Disorders Involving the Liver and Spleen

  • Chapter
  • First Online:
Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

  • 906 Accesses

Abstract

In addition to malignant disease, the spleen and liver can develop benign disorders or be involved by other systemic diseases. These diseases include ectopic spleen which is a benign condition that can cause a diagnostic dilemma when confused with malignant intraabdominal lesions. Also, systemic infectious, autoimmune and inflammatory diseases may involve the spleen and liver posing a diagnostic challenge and may require treatment planning. Therefore, it is important to be aware of splenic and hepatic manifestations of the systemic disease and accurately diagnose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fremont RD, Rice TW. Splenosis: a review. South Med J. 2007;100:589–93.

    Article  PubMed  Google Scholar 

  2. Halpert B, Eaton WL. Lesions in accessory spleens. AMA Arch Pathol. 1954;57:501–4.

    CAS  PubMed  Google Scholar 

  3. Kawamoto S, Johnson PT, Hall H, Cameron JL, Hruban RH, Fishman EK. Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging. 2012;37:812–27.

    Article  PubMed  Google Scholar 

  4. Abu Hilal M, Harb A, Zeidan B, Steadman B, Primrose JN, Pearce NW. Hepatic splenosis mimicking HCC in a patient with hepatitis C liver cirrhosis and mildly raised alpha feto protein; the important role of explorative laparoscopy. World J Surg Oncol. 2009;7:1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Madjar S, Weissberg D. Thoracic splenosis. Thorax. 1994;49:1020–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bajwa SA, Kasi A. Spleen, accessory. Treasure Island: StatPearls; 2018.

    Google Scholar 

  7. Tandon YK, Coppa CP, Purysko AS. Splenosis: a great mimicker of neoplastic disease. Abdom Radiol. 2018;43:3054.

    Article  Google Scholar 

  8. Dodds WJ, Taylor AJ, Erickson SJ, Stewart ET, Lawson TL. Radiologic imaging of splenic anomalies. AJR Am J Roentgenol. 1990;155:805–10.

    Article  CAS  PubMed  Google Scholar 

  9. Gayer G, Zissin R, Apter S, Atar E, Portnoy O, Itzchak Y. CT findings in congenital anomalies of the spleen. Br J Radiol. 2001;74:767–72.

    Article  CAS  PubMed  Google Scholar 

  10. Imbriaco M, Camera L, Manciuria A, Salvatore M. A case of multiple intra-abdominal splenosis with computed tomography and magnetic resonance imaging correlative findings. World J Gastroenterol. 2008;14:1453–5.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stanek A, Stefaniak T, Makarewicz W, Kaska L, Podgorczyk H, Hellman A, Lachinski A. Accessory spleens: preoperative diagnostics limitations and operational strategy in laparoscopic approach to splenectomy in idiopathic thrombocytopenic purpura patients. Langenbeck’s Arch Surg. 2005;390:47–51.

    Article  Google Scholar 

  12. Sohawon D, Lau KK, Lau T, Bowden DK. Extra-medullary haematopoiesis: a pictorial review of its typical and atypical locations. J Med Imaging Radiat Oncol. 2012;56:538–44.

    Article  PubMed  Google Scholar 

  13. Kim CH. Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med. 2010;1:13–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Macki M, Bydon M, Papademetriou K, Gokaslan Z, Bydon A. Presacral extramedullary hematopoiesis: an alternative hypothesis. J Clin Neurosci. 2013;20:1664–8.

    Article  PubMed  Google Scholar 

  15. Johns JL, Christopher MM. Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of development, and occurrence in animals. Vet Pathol. 2012;49:508–23.

    Article  CAS  PubMed  Google Scholar 

  16. Miwa Y, Hayashi T, Suzuki S, Abe S, Onishi I, Kirimura S, Kitagawa M, Kurata M. Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis. Pathology. 2013;45:408–16.

    Article  CAS  PubMed  Google Scholar 

  17. O’Malley DP, Orazi A, Wang M, Cheng L. Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia. Mod Pathol. 2005;18:1562–8.

    Article  PubMed  CAS  Google Scholar 

  18. Konoplev S, Hsieh PP, Chang CC, Medeiros LJ, Lin P. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis. Hum Pathol. 2007;38:1760–3.

    Article  PubMed  Google Scholar 

  19. Thambi R, Devi L, Balachandran K, Poothiode U. Extramedullary hematopoiesis as a ‘clue’ to diagnosis of hepatoblastoma on fine needle aspiration cytology: a report of two cases. J Cytol. 2013;30:198–200.

    Article  PubMed  PubMed Central  Google Scholar 

  20. von Schweinitz D, Schmidt D, Fuchs J, Welte K, Pietsch T. Extramedullary hematopoiesis and intratumoral production of cytokines in childhood hepatoblastoma. Pediatr Res. 1995;38:555–63.

    Article  Google Scholar 

  21. Zhang HZ, Li Y, Liu X, Chen BR, Yao GH, Peng YN. Extramedullary hematopoiesis: a report of two cases. Exp Ther Med. 2016;12:3859–62.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Papavasiliou C. Clinical expressions of the expansion of the bone marrow in the chronic anemias: the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:605–12.

    Article  CAS  PubMed  Google Scholar 

  23. Gupta P, Naran A, Auh YH, Chung JS. Focal intrahepatic extramedullary hematopoiesis presenting as fatty lesions. AJR Am J Roentgenol. 2004;182:1031–2.

    Article  PubMed  Google Scholar 

  24. Roberts JL, Fishman EK, Hartman DS, Sanders R, Goodman Z, Siegelman SS. Lipomatous tumors of the liver: evaluation with CT and US. Radiology. 1986;158:613–7.

    Article  CAS  PubMed  Google Scholar 

  25. Murakami T, Nakamura H, Hori S, Nakanishi K, Mitani T, Kozuka T, Kimura Y, Monden M, Wakasa K, Sakurai M. Angiomyolipoma of the liver. Ultrasound, CT, MR imaging and angiography. Acta Radiol. 1993;34:392–4.

    Article  CAS  PubMed  Google Scholar 

  26. Littrell LA, Carter JM, Broski SM, Wenger DE. Extra-adrenal myelolipoma and extramedullary hematopoiesis: imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma. Eur J Radiol. 2017;93:185–94.

    Article  PubMed  Google Scholar 

  27. Burke JS, Osborne BM. Localized reactive lymphoid hyperplasia of the spleen simulating malignant lymphoma. A report of seven cases. Am J Surg Pathol. 1983;7:373–80.

    Article  CAS  PubMed  Google Scholar 

  28. Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993;118:45–58.

    Article  CAS  PubMed  Google Scholar 

  29. Siliezar MM, Munoz CC, Solano-Iturri JD, Ortega-Comunian L, Mollejo M, Montes-Moreno S, Piris MA. Spontaneously ruptured spleen samples in patients with infectious mononucleosis: analysis of histology and lymphoid subpopulations. Am J Clin Pathol. 2018;150:310–7.

    Article  CAS  PubMed  Google Scholar 

  30. Rieux-Laucat F, Magerus-Chatinet A, Neven B. The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol. 2018;38:558–68.

    Article  CAS  PubMed  Google Scholar 

  31. Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123:1989–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, Lanzarotti N, Stolzenberg MC, Bader-Meunier B, Aladjidi N, Chantrain C, Bertrand Y, Jeziorski E, Leverger G, Michel G, Suarez F, Oksenhendler E, Hermine O, Blanche S, Picard C, Fischer A, Rieux-Laucat F. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118:4798–807.

    Article  CAS  PubMed  Google Scholar 

  33. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, Sneller MC, Puck JM, Lenardo MJ, Elenitoba-Johnson KS, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Neuhauser TS, Derringer GA, Thompson LD, Fanburg-Smith JC, Aguilera NS, Andriko J, Chu WS, Abbondanzo SL. Splenic inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunophenotypic study of 12 cases. Arch Pathol Lab Med. 2001;125:379–85.

    Article  CAS  PubMed  Google Scholar 

  35. Cheuk W, Chan JK, Shek TW, Chang JH, Tsou MH, Yuen NW, Ng WF, Chan AC, Prat J. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001;25:721–31.

    Article  CAS  PubMed  Google Scholar 

  36. Horiguchi H, Matsui-Horiguchi M, Sakata H, Ichinose M, Yamamoto T, Fujiwara M, Ohse H. Inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen. Pathol Int. 2004;54:124–31.

    Article  PubMed  Google Scholar 

  37. Li XQ, Cheuk W, Lam PW, Wang Z, Loong F, Yeong ML, Browett P, McCall J, Chan JK. Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions. Am J Surg Pathol. 2014;38:646–53.

    Article  PubMed  Google Scholar 

  38. Chen Y, Shi H, Li H, Zhen T, Han A. Clinicopathological features of inflammatory pseudotumour-like follicular dendritic cell tumour of the abdomen. Histopathology. 2016;68:858–65.

    Article  PubMed  Google Scholar 

  39. Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol Clin North Am. 2018;32:11–21.

    Article  PubMed  Google Scholar 

  40. Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, Mughal T, Ali S, Ohgami RS. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018;2:481–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Chang KC, Wang YC, Hung LY, Huang WT, Tsou JH, M Jones D, Song HL, Yeh YM, Kao LY, Medeiros LJ. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Mod Pathol. 2014;27:823–31.

    Article  CAS  PubMed  Google Scholar 

  42. Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123:2924–33.

    Article  CAS  PubMed  Google Scholar 

  43. Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol. 2016;3:e163–75.

    Article  PubMed  Google Scholar 

  44. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129:1646–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3–17.

    Article  PubMed  Google Scholar 

  46. Kujat C, Muller-Leisse C, Lorbacher P, Seufert R, Falk S, Stutte HJ. A unifocal manifestation of Castleman’s disease (angiofollicular lymphatic hyperplasia) in the spleen. Rofo. 1990;152:615–7.

    Article  CAS  PubMed  Google Scholar 

  47. Taura T, Takashima S, Shakudo M, Kaminou T, Yamada R, Isoda K. Castleman’s disease of the spleen: CT, MR imaging and angiographic findings. Eur J Radiol. 2000;36:11–5.

    Article  CAS  PubMed  Google Scholar 

  48. Lee HJ, Jeon HJ, Park SG, Park CY. Castleman’s disease of the spleen. World J Gastroenterol. 2015;21:1675–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Sbrana F, Zhou D, Zamfirova I, Leonardi N. Castleman’s disease: a rare presentation in a retroperitoneal accessory spleen, treated with a minimally invasive robotic approach. J Surg Case Rep. 2017;2017:rjx195.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Mantas D, Damaskos C, Dailiani P, Samarkos M, Korkolopoulou P. Castleman’s disease of the spleen. Acta Chir Belg. 2017;117:203–8.

    Article  PubMed  Google Scholar 

  51. Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013;53:57–61.

    Article  PubMed  Google Scholar 

  52. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21:266–78.

    Article  PubMed  Google Scholar 

  53. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017;129:1658–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Rahmouni A, Golli M, Mathieu D, Anglade MC, Charlotte F, Vasile N. Castleman disease mimicking liver tumor: CT and MR features. J Comput Assist Tomogr. 1992;16:699–703.

    Article  CAS  PubMed  Google Scholar 

  55. Cirillo RL Jr, Vitellas KM, Deyoung BR, Bennett WF. Castleman disease mimicking a hepatic neoplasm. Clin Imaging. 1998;22:124–9.

    Article  PubMed  Google Scholar 

  56. Uzunlar AK, Ozates M, Yaldiz M, Buyukbayram H, Ozaydin M. Castleman’s disease in the porta hepatis. Eur Radiol. 2000;10:1913–5.

    Article  CAS  PubMed  Google Scholar 

  57. Karami H, Sahebpour AA, Ghasemi M, Karami H, Dabirian M, Vahidshahi K, Masiha F, Shahmohammadi S. Hyaline vascular-type Castleman’s disease in the hilum of liver: a case report. Cases J. 2010;3:74.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Jang SY, Kim BH, Kim JH, Ha SH, Hwang JA, Yeon JW, Kim KH, Paik SY. A case of Castleman’s disease mimicking a hepatocellular carcinoma: a case report and review of literature. Korean J Gastroenterol. 2012;59:53–7.

    Article  PubMed  Google Scholar 

  59. Miyoshi H, Mimura S, Nomura T, Tani J, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, et al. A rare case of hyaline-type Castleman disease in the liver. World J Hepatol. 2013;5:404–8.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Dong A, Dong H, Zuo C. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT. Clin Nucl Med. 2014;39:e69–72.

    Article  PubMed  Google Scholar 

  61. Maundura M, Hayward G, McKee C, Koea JB. Primary Castleman’s disease of the liver. J Gastrointest Surg. 2017;21:417–9.

    Article  PubMed  Google Scholar 

  62. Lv K, Zhang CL, Xu MS. Primary Castleman’s disease in the liver: a case report and literature review. Mol Clin Oncol. 2018;8:579–81.

    Google Scholar 

  63. Bower M. How I treat HIV-associated multicentric Castleman disease. Blood. 2010;116:4415–21.

    Article  CAS  PubMed  Google Scholar 

  64. Casper C, Munshi N, Ke X, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, et al. A multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease. Blood. 2013;122:505.

    Article  Google Scholar 

  65. Masab M, Farooq H. Kikuchi disease. Treasure Island: StatPearls; 2018.

    Google Scholar 

  66. Quintas-Cardama A, Fraga M, Cozzi SN, Caparrini A, Maceiras F, Forteza J. Fatal Kikuchi-Fujimoto disease: the lupus connection. Ann Hematol. 2003;82:186–8.

    Article  CAS  PubMed  Google Scholar 

  67. Pileri S, Kikuchi M, Helbron D, Lennert K. Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982;395:257–71.

    Article  CAS  PubMed  Google Scholar 

  68. Turner RR, Martin J, Dorfman RF. Necrotizing lymphadenitis. A study of 30 cases. Am J Surg Pathol. 1983;7:115–23.

    Article  CAS  PubMed  Google Scholar 

  69. O’Neill D, O’Grady J, Variend S. Child fatality associated with pathological features of histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). Pediatr Pathol Lab Med. 1998;18:79–88.

    PubMed  Google Scholar 

  70. Chan JK, Wong KC, Ng CS. A fatal case of multicentric Kikuchi’s histiocytic necrotizing lymphadenitis. Cancer. 1989;63:1856–62.

    Article  CAS  PubMed  Google Scholar 

  71. Tsai MK, Huang HF, Hu RH, Lee PH, Lee CJ, Chao SH, Hsu HC, Ko WJ, Chu SH. Fatal Kikuchi-Fujimoto disease in transplant recipients: a case report. Transplant Proc. 1998;30:3137–8.

    Article  CAS  PubMed  Google Scholar 

  72. Rudniki C, Kessler E, Zarfati M, Turani H, Bar-Ziv Y, Zahavi I. Kikuchi’s necrotizing lymphadenitis: a cause of fever of unknown origin and splenomegaly. Acta Haematol. 1988;79:99–102.

    Article  CAS  PubMed  Google Scholar 

  73. Shusang V, Marelli L, Beynon H, Davies N, Patch D, Dhillon AP, Burroughs AK. Autoimmune hepatitis associated with Kikuchi-Fujimoto’s disease. Eur J Gastroenterol Hepatol. 2008;20:79–82.

    Article  PubMed  Google Scholar 

  74. Toral Revuelta JR, Martinez Ruiz M, Llobell Segui G, Peralba Vano JI, Mellado del Rey F, Martos Pelegrin J. Pseudometastatic hepatic lesions and Kikuchi necrotizing lymphadenitis. An Med Interna. 1993;10:346–8.

    CAS  PubMed  Google Scholar 

  75. Pepe F, Disma S, Teodoro C, Pepe P, Magro G. Kikuchi-Fujimoto disease: a clinicopathologic update. Pathologica. 2016;108:120–9.

    CAS  PubMed  Google Scholar 

  76. Pileri SA, Facchetti F, Ascani S, Sabattini E, Poggi S, Piccioli M, Rondelli D, Vergoni F, Zinzani PL, Piccaluga PP, et al. Myeloperoxidase expression by histiocytes in Kikuchi’s and Kikuchi-like lymphadenopathy. Am J Pathol. 2001;159:915–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Umehara H, Nakajima A, Nakamura T, Kawanami T, Tanaka M, Dong L, Kawano M. IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol. 2014;26:585–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538–46.

    Article  CAS  PubMed  Google Scholar 

  79. Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Chen JH, Deshpande V. IgG4-related disease and the liver. Gastroenterol Clin North Am. 2017;46:195–216.

    Article  PubMed  Google Scholar 

  81. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.

    Article  CAS  PubMed  Google Scholar 

  82. Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Kloppel G, Heathcote JG, Khosroshahi A, Ferry JA, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.

    Article  PubMed  Google Scholar 

  84. Hirota M, Satoh K, Kikuta K, Masamune A, Kume K, Hamada S, Satoh A, Kanno A, Unno J, Ito H, et al. Early detection of low enhanced pancreatic parenchyma by contrast-enhanced computed tomography predicts poor prognosis of patients with acute pancreatitis. Pancreas. 2012;41:1099–104.

    Article  PubMed  Google Scholar 

  85. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, Topazian MD, Clain JE, Pearson RK, Petersen BT, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.

    Article  PubMed  Google Scholar 

  86. Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, Lauwers GY. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009;22:1287–95.

    Article  CAS  PubMed  Google Scholar 

  87. Gaeta R, Donati F, Kauffmann EF, Campani D. A splenic IgG4+ Sclerosing Angiomatoid Nodular Transformation (SANT) treated by Hemisplenectomy: a radiologic, histochemical, and immunohistochemical study. Appl Immunohistochem Mol Morphol. 2017; https://doi.org/10.1097/PAI.0000000000000560.

  88. Joshi D, Webster GJ. Biliary and hepatic involvement in IgG4-related disease. Aliment Pharmacol Ther. 2014;40:1251–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

    Haipeng Shao

  2. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA

    Deniz Peker

Authors
  1. Haipeng Shao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deniz Peker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haipeng Shao .

Editor information

Editors and Affiliations

  1. Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA

    Ling Zhang

  2. Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA

    Haipeng Shao

  3. Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Serhan Alkan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shao, H., Peker, D. (2020). Benign Hematologic Disorders Involving the Liver and Spleen. In: Zhang, L., Shao, H., Alkan, S. (eds) Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver. Springer, Cham. https://doi.org/10.1007/978-3-030-37708-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-37708-3_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-37707-6

  • Online ISBN: 978-3-030-37708-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation